Sandra Mancilla Zamora Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups. Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca LinkedIn Twitter Orcid Email Sandra Mancilla Zamora LinkedIn Twitter Orcid Email Institutions of which they are part Research technician Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Anatomy technician with more than 20 years of experience, responsible for the histology section of the area of Functional Validation and Preclinical Studies (FVPR) and the Drugs Delivery Targeting (DDT) group of the VHIR. I give assistance to the in vitro section and the in vivo section of FVPR, which is part of the ICTS of Nanbiosis providing support services to companies / research groups.
Degrees: Stable animal experimentation course. ABC function in 2020 Senior Clinical Analysis Technician in 2005 Higher Techniques in Pathological Anatomy and Cytology in 2001. Currently Vall d'Hebron University Hospital. VHIR-CIBBIM. FVPR since 01/11/2017 Technician in charge of the histology section of FVPR and the DDT group of the VHIR. With knowledge in environment and quality management at ISO 9001. Application management, internal positions… They also carry out research with various projects where I am in charge of the processing of the samples, making blocks, cuts, stains, immune. I give assistance the in vitro section (cell culture) and molecular biology techniques (western blot, enzymatic activities ...) and the in vivo section helping to prepare treatments, subcutaneous, intravenous cell inoculation, mammary, control of mice’s evolution, weight, tumor size, etc., necropsies and collection of biological samples for further processing. Responsible for the control of own equipment, maintenance, verification and calibration. Order control and organization of the general laboratory.
Projects Vesículas extracelulares para el tratamiento de enfermeades lisosomales (Título provisional) IP: Vesículas extracelulares para el tratamiento de enfermeades lisosomales (Título provisional) Collaborators: Laura García Latorre, Guillem Pintos Morell, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Marc Miquel Moltó Abad, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos, Zamira Vanessa Diaz Riascos Funding agency: Instituto de Salud Carlos III Funding: 153670 Reference: PI21/00936 Duration: 01/01/2022 - 30/06/2025 NanoDIRE-CT - Uso de nanobodies para terapia dirigida contra células madre tumorales IP: NanoDIRE-CT - Uso de nanobodies para terapia dirigida contra células madre tumorales Collaborators: Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael, Simon Schwartz Navarro Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 322172.61 Reference: RTC2019-006809-1 Duration: 01/09/2020 - 31/12/2023 Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH IP: María José Buzón Gómez Collaborators: Desenvolupament de noves nanopartícules funcionals dirigides al nòdul limfàtic per a l'eliminació del reservori latent de VIH, Félix Pumarola Segura, Juan Lorente Guerrero, Laura García Latorre, Jordi Temprana Salvador, Joaquin Seras Franzoso, Marc Pellicer Sarasa, Simon Schwartz Navarro, Jordi Navarro Mercadé, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Judit Grau Exposito, Meritxell Genesca Ferrer, Fernanda Raquel Da Silva Andrade, Diana Fernandes de Rafael Funding agency: Fundació La Marató de TV3 Funding: 199998.75 Reference: 20180510 Duration: 10/05/2019 - 31/12/2022 Evolvable platform for designing cancer treatment strategies using nanoparticles (EVO-NANO) IP: Evolvable platform for designing cancer treatment strategies using nanoparticles (EVO-NANO) Collaborators: Joaquin Seras Franzoso, Simon Schwartz Navarro, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Belen Garcia Prats Funding agency: EUROPEAN COMMISSION Funding: 568847.5 Reference: EVO-NANO_H2020FETOPEN2017 Duration: 01/10/2018 - 31/03/2022 Pagination First page « Previous page ‹ Page 1 Current page 2 Page 3 Next page › Last page »
